BioInsights
Resources for healthcare investors
The Piper Sandler BioInsights research platform provides in-depth analyses across a diverse range of innovative and emerging therapeutic modalities, novel drug targets and disease states, through monthly thematic reports, expert events, catalyst calendars and more.
40
Thematic reports since 2019
161
Average page count per report*
27
Average companies profiled per report*
29+
Topics covered since 2019
Market-Driven, Actionable Insights
Piper Sandler’s thematic BioInsights reports dive deep into a diverse array of disease pathways, indications of interest and novel therapeutic modalities. The reports explore current and emerging competitive landscapes and provide detailed profiles of key public and private players in each space – reviewing relevant pipeline and marketed assets, available clinical data and upcoming catalysts of interest.
Emerging themes in biopharma
Artificial intelligence and machine learning, the evolution of generics and biosimilars.
Innovative therapeutic modalities and targets
Cell and gene therapies, engineered cytokines, RNA medicines, gene editing, drugging transcription factors, protein degradation, TGF-beta, and precision cardiovascular medicine.
Novel strategies to address disease indications
Chronic hepatitis B, women’s and men’s health, cystic fibrosis, medical dermatology, oncology, pain, epilepsy, gastrointestinal disorders, psychiatry and mood disorders, renal disorders, movement disorders, and sickle cell disease.
Catalyst Calendars
Our catalyst calendars include summaries of key biopharma events within the Piper Sandler coverage universe.
Key Opinion Leader Day Recaps
Key Opinion Leader day recaps provide detailed thoughts from panel discussions and key takeaways from industry leaders.
Conferences & Events
We bring together key industry executives and our own professionals to provide multiple perspectives, investigate critical trends, and identify the leaders in biopharma.
Insights
Conferences & Events
36th Annual Healthcare Conference
*Data for January 2021 through December 2022.